Found: 51
Select item for more details and to access through your institution.
Cross‐sectional investigation of synaptic markers Neurogranin and BACE1 in CSF from the AIBL study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078048
- By:
- Publication type:
- Article
Qualification of classical biomarkers for Alzheimer's Disease in a multiplex format in blood using a new technology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.067497
- By:
- Publication type:
- Article
Preparation and qualification of soluble amyloid beta oligomers for use in bioanalytic assays supporting Alzheimer's disease therapeutics.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.067489
- By:
- Publication type:
- Article
Cerebrospinal fluid biomarker levels are not affected by aspiration or gravity drip extraction methods in Alzheimer's disease: The AIBL study: Biomarkers (non‐neuroimaging): Method development and validation.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.046703
- By:
- Publication type:
- Article
Comparison of two analytical platforms for blood‐based surrogate biomarkers of amyloid pathology: Biomarkers (non‐neuroimaging) / plasma/serum/urine biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045110
- By:
- Publication type:
- Article
CSF levels of the BACE1 substrate Neuregulin1 correlate with cognition and synaptic biomarkers in Alzheimer's disease: Biomarkers (non‐neuroimaging) / Novel biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.037097
- By:
- Publication type:
- Article
O5‐05‐02: CSF BIOMARKERS OF SYNAPTIC DAMAGE (NEUROGRANIN, SNAP25) AND INTERNEURON‐DEPENDENT SYNAPTIC HOMEOSTASIS (NPTX2) IMPROVE DIAGNOSTIC CLASSIFICATION OF MCI AND AD AND CORRELATE WITH COGNITION.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1626, doi. 10.1016/j.jalz.2019.06.4859
- By:
- Publication type:
- Article
O3‐12‐03: THE CSF SYNAPTIC BIOMARKER BACE1 CORRELATES WITH COGNITION IN MCI AND ALZHEIRMER DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P916, doi. 10.1016/j.jalz.2019.06.4692
- By:
- Publication type:
- Article
P2‐256: NPTX2 LEVELS IN CSF AS POTENTIAL PREDICTOR OF COGNITIVE DYSFUNCTION IN THE AD CONTINUUM.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P682, doi. 10.1016/j.jalz.2019.06.2663
- By:
- Publication type:
- Article
P2‐253: ANTEMORTEM CSF α‐SYNUCLEIN PREDICTS TIME UNTIL DEATH IN AN AUTOPSY COHORT.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P681, doi. 10.1016/j.jalz.2019.06.2660
- By:
- Publication type:
- Article
O2‐05‐03: CHARACTERIZATION AND TRANSFER OF A NOVEL PLASMA Aβ1‐42/Aβ1‐40 SIMOA ASSAY FOR INTEGRATION INTO THE CLINIC.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P546, doi. 10.1016/j.jalz.2019.06.4477
- By:
- Publication type:
- Article
F2‐07‐04: PLASMA AMYLOID BETA 1–42 AND 1–40 MEASURED BY A NOVEL SIMOA ASSAY AS A DIAGNOSTIC TOOL FOR ALZHEIMER'S DISEASE PATHOLOGY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P527, doi. 10.1016/j.jalz.2019.06.4443
- By:
- Publication type:
- Article
P1‐237: IMPROVED DIAGNOSTIC ACCURACY USING THE CEREBROSPINAL FLUID AMYLOID BETA 1‐42/1‐40 RATIO.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P327, doi. 10.1016/j.jalz.2019.06.792
- By:
- Publication type:
- Article
P1‐230: MEMORY FUNCTION IS ASSOCIATED WITH TAU PATHOLOGY IN PARKINSON'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P323, doi. 10.1016/j.jalz.2019.06.785
- By:
- Publication type:
- Article
O1‐07‐04: CSF BIOMARKERS OF AMYLOID, TAU AND SYNAPTIC DAMAGE (NEUROGRANIN, SNAP25) AND INTERNEURON‐DEPENDENT SYNAPTIC HOMEOSTASIS (NPTX2) IN CSF AS PREDICTORS OF COGNITIVE PROGRESSION IN MCI AND AD.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P212, doi. 10.1016/j.jalz.2019.06.4556
- By:
- Publication type:
- Article
F1‐05‐01: LAB‐RELATED PRE‐ANALYTICAL FACTORS INFLUENCING PLASMA AMYLOID BETA CONCENTRATIONS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P183, doi. 10.1016/j.jalz.2019.06.4385
- By:
- Publication type:
- Article
F1‐03‐01: CSF BIOMARKERS RELATED TO NEURODEGENERATION AS PREDICTORS OF COGNITIVE PROGRESSION IN MCI AND ELDERLY CONTROLS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P178, doi. 10.1016/j.jalz.2019.06.4377
- By:
- Publication type:
- Article
P3‐246: C‐REACTIVE PROTEIN, PLASMA AMYLOID BETA LEVELS AND MRI MARKERS: THE ROTTERDAM STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1166, doi. 10.1016/j.jalz.2018.06.1605
- By:
- Publication type:
- Article
O3‐09‐06: A PROTOTYPE SIMOA ASSAY QUANTIFYING PLASMA AMYLOID BETA 1‐42 AND 1‐40 ISOFORMS CAN DIFFERENTIATE PARTICIPANTS WITH AD FROM HEALTHY CONTROL SUBJECTS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1039, doi. 10.1016/j.jalz.2018.06.2824
- By:
- Publication type:
- Article
O3‐09‐04: PLASMA AMYLOID β LEVELS, CEREBRAL ATROPHY AND DEMENTIA RISK: THE ROTTERDAM STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1037, doi. 10.1016/j.jalz.2018.06.2822
- By:
- Publication type:
- Article
O2‐09‐04: HARMONIZATION OF IMMUNOCHEMICAL METHODS FOR MEASUREMENT OF α‐SYNUCLEIN IN HUMAN CEREBROSPINAL FLUID: A ROUND ROBIN STUDY APPROACH.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P642, doi. 10.1016/j.jalz.2018.06.2691
- By:
- Publication type:
- Article
O2‐09‐02: A UNIFIED PRE‐ANALYTICAL PROTOCOL FOR HANDLING OF CSF SAMPLES BEFORE ANALYSES OF AD BIOMARKER LEVELS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P641, doi. 10.1016/j.jalz.2018.06.2689
- By:
- Publication type:
- Article
P1‐305: ANALYTICAL VALIDATION OF FULLY AUTOMATED CHEMILUMINESCENCE IMMUNOASSAYS FOR CSF BETA‐AMYLOID 1‐40 AND 1‐42 ANALYSIS FOR USE IN CLINICAL TRIALS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P407, doi. 10.1016/j.jalz.2018.06.312
- By:
- Publication type:
- Article
P1‐273: EVALUATION OF CERTIFIED REFERENCE MATERIALS FOR BETA‐AMYLOID 1‐42 IN EUROIMMUN BETA‐AMYLOID 1‐42 ELISA AND CHLIA.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P387, doi. 10.1016/j.jalz.2018.06.279
- By:
- Publication type:
- Article
A NOVEL COLORIMETRIC ELISA FOR QUANTIFICATION OF TAU, PHOSPHORYLATED AT THREONINE 181, IN CEREBROSPINAL FLUID.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P353, doi. 10.1016/j.jalz.2017.06.287
- By:
- Publication type:
- Article
PLASMA AMYLOID BETA LEVELS, CEREBRAL SMALL-VESSEL DISEASES AND COGNITION: THE ROTTERDAM STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1035, doi. 10.1016/j.jalz.2017.06.1461
- By:
- Publication type:
- Article
THE CSF Aβ(1-42)/Aβ(1-40) RATIO IMPROVES THE CLINICAL UTILITY OF Aβ(1-42) BY ITS IMPACT AT ANALYTICAL AND CLINICAL LEVELS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P198, doi. 10.1016/j.jalz.2017.07.059
- By:
- Publication type:
- Article
ASSOCIATION BETWEEN NOCTURNAL AMYLOID BETA FLUCTUATIONS AND SLEEP.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P559, doi. 10.1016/j.jalz.2017.07.166
- By:
- Publication type:
- Article
ANALYTICAL PERFORMANCE CHARACTERISTICS OF A NOVEL IMMUNOASSAY FOR THE QUANTIFICATION OF BACE-1 IN HUMAN CEREBROSPINAL FLUID.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P357, doi. 10.1016/j.jalz.2017.06.296
- By:
- Publication type:
- Article
SYNAPTIC MARKERS IN LIQUOR INVERSELY CORRELATE WITH GRAY MATTER VOLUME IN COGNITIVELY HEALTHY INDIVIDUALS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P215, doi. 10.1016/j.jalz.2017.07.091
- By:
- Publication type:
- Article
USE FOR CALIBRATION OF CERTIFIED REFERENCE MATERIALS FOR Aβ1-42.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1512, doi. 10.1016/j.jalz.2017.07.630
- By:
- Publication type:
- Article
DIFFERENCES IN ANALYTICAL SELECTIVITY OF β-AMYLOID (1-42) IMMUNOASSAYS EXPLAIN DISCORDANT RESULTS IN STUDY COMPARISONS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1316, doi. 10.1016/j.jalz.2017.06.2019
- By:
- Publication type:
- Article
TWIN CORRELATIONS FOR AMYLOID PATHOLOGY MEASURED WITH POSITRON EMISSION TOMOGRAPHY AND IN CEREBROSPINAL FLUID IN COGNITIVELY HEALTHY ELDERLY MONOZYGOTIC TWIN PAIRS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P559, doi. 10.1016/j.jalz.2017.07.167
- By:
- Publication type:
- Article
TWIN CORRELATIONS FOR AMYLOID PATHOLOGY MEASURED WITH POSITRON EMISSION TOMOGRAPHY AND IN CEREBROSPINAL FLUID IN COGNITIVELY HEALTHY ELDERLY MONOZYGOTIC TWIN PAIRS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P47, doi. 10.1016/j.jalz.2017.06.2331
- By:
- Publication type:
- Article
ANALYTICAL PERFORMANCE CHARACTERISTICS OF A PROTOTYPE IMMUNOASSAY FOR QUANTIFICATION OF ALPHA-SYNUCLEIN IN HUMAN CEREBROSPINAL FLUID.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P702, doi. 10.1016/j.jalz.2017.06.890
- By:
- Publication type:
- Article
ASSOCIATIONS OF PLASMA AMYLOID BETA LEVELS WITH SEVERITY AND PROGRESSION OF CEREBRAL SMALL VESSEL DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1479, doi. 10.1016/j.jalz.2017.07.554
- By:
- Publication type:
- Article
DIFFERENTIAL ROLE OF CSF FATTY ACID BINDING PROTEIN 3, α-SYNUCLEIN AND ALZHEIMER’S DISEASE CORE BIOMARKERS IN LEWY BODY DISORDERS AND ALZHEIMER’S DEMENTIA.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P334, doi. 10.1016/j.jalz.2017.06.057
- By:
- Publication type:
- Article
PROGRESS ON THE DEVELOPMENT OF CERTIFIED REFERENCE MATERIALS FOR Aβ1-42.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1512, doi. 10.1016/j.jalz.2017.07.629
- By:
- Publication type:
- Article
ALPHA-SYNUCLEIN BIOMARKER ANALYSIS: ANALYTICAL PERFORMANCE AND INTER-LABORATORY PRECISION USING A NEW COLORIMETRIC ELISA.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1316, doi. 10.1016/j.jalz.2017.06.2018
- By:
- Publication type:
- Article
PERFORMANCE EVALUATION OF NEW ABSORBANCE-BASED ELISAS FOR MEASURING DIFFERENT ALPHA-SYNUCLEIN (A-SYN) SPECIES IN CSF AND PLASMA.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P677, doi. 10.1016/j.jalz.2016.06.1330
- By:
- Publication type:
- Article
DIAGNOSTIC PERFORMANCE OF AN AUTOMATED ELISA SYSTEM FOR ALZHEIMER’S DISEASE DETECTION.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P478, doi. 10.1016/j.jalz.2016.06.942
- By:
- Publication type:
- Article
IMPORTANCE OF DIFFERENT FACTORS FOR ANALYSIS OF β-AMYLOID ISOFORMS IN CSF AND PROPOSAL FOR AN IMPROVED STANDARD OPERATING PROCEDURE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P480, doi. 10.1016/j.jalz.2016.06.947
- By:
- Publication type:
- Article
SUPPRESSION OF TAU INCREASE IN CEREBROSPINAL FLUID OF APP TRANSGENIC MICE PROVIDES EVIDENCE FOR DOWNSTREAM EFFECT OF BACE1 INHIBITION.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P1045, doi. 10.1016/j.jalz.2016.06.2173
- By:
- Publication type:
- Article
IMPROVEMENT OF REPRODUCIBILITY FOR CSF BIOMARKER ANALYSIS BY INTEGRATION OF AUTOMATION IN THE TEST PROCEDURES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P480, doi. 10.1016/j.jalz.2016.06.948
- By:
- Publication type:
- Article
PERFORMANCE TESTING AND ANALYTICAL VALIDATION OF NEW ELISAS FOR B-AMYLOID ISOFORMS (AB(1-38), AB(1-40), AB(1-42)) IN PLASMA.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P893, doi. 10.1016/j.jalz.2016.06.1848
- By:
- Publication type:
- Article
EVALUTIONTM, A NOVEL MULTIPLEX TECHNOLOGY FOR SIMULTANEOUS QUANTIFICATION OF INFLAMMATION MARKERS, β-AMYLOID AND TAU PROTEINS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P479, doi. 10.1016/j.jalz.2016.06.945
- By:
- Publication type:
- Article
Limited impact of CSF biomarkers variability on clinical diagnosis in autopsy-confirmed Alzheimer’s disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P296, doi. 10.1016/j.jalz.2015.07.407
- By:
- Publication type:
- Article
The path to regulatory qualification of cerebrospinal fluid biomarkers as enrichment tools in clinical trials of patients with early Alzheimer’s disease: For the coalition against major diseases.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P296, doi. 10.1016/j.jalz.2015.07.406
- By:
- Publication type:
- Article
Alzheimer Disease Biomarker Testing in Cerebrospinal Fluid: A Method to Harmonize Assay Platforms in the Absence of an Absolute Reference Standard.
- Published in:
- Clinical Chemistry, 2013, v. 59, n. 4, p. 710, doi. 10.1373/clinchem.2012.201830
- By:
- Publication type:
- Article
Critical Steps to be Taken into Consideration Before Quantification of β-Amyloid and Tau Isoforms in Blood can be Implemented in a Clinical Environment.
- Published in:
- Neurology & Therapy, 2019, v. 8, p. 129, doi. 10.1007/s40120-019-00166-3
- By:
- Publication type:
- Article